New Reactor Technology Enables Larger Scale Manufacture of Fragile Cells

Matthieu Egloff, product director with ATMI LifeSciences, discusses the need for larger, special reactors that can provide the necessary conditions for the production of fragile cells on a larger scale.
Mar 13, 2013